Atai Life Sciences N.V.

NASDAQ:ATAI

1.5 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -150.049-40.224-157.417-174.244-178.625-24.384
Depreciation & Amortization 0.4730.3190.1680.0470.0240.006
Deferred Income Tax 005.07439.13556.3467.536
Stock Based Compensation 25.4932.98242.37563.36267.1580.057
Change In Working Capital -9.27.469-3.335-7.6044.45-0.126
Accounts Receivables 000000
Inventory 000000
Accounts Payables -1.8722.138-3.0342.31.7040.249
Other Working Capital -7.3285.331-0.301-9.9042.746-0.375
Other Non Cash Items 50.849-84.6648.66816.05829.8819.065
Operating Cash Flow -82.437-84.118-104.467-63.246-20.766-7.846
Investing Activities:
Investments In Property Plant And Equipment 0-0.59-1.024-1.128-0.059-0.019
Acquisitions Net 0-0.4430-52.937-2.088-0.456
Purchases Of Investments 0-185.262-309.658-23.658-23.92-11.55
Sales Maturities Of Investments 83.728139.469226.834-0.955010.313
Other Investing Activites -24.556-6.469-3-2.598-2.204-7.319
Investing Cash Flow 59.172-53.295-86.848-81.276-28.271-9.031
Financing Activities:
Debt Repayment 50151.58832.5030
Common Stock Issued 00.2254.636409.88482.43942.684
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0.374-8.3555.785-1.61-1.89-2.295
Financing Cash Flow 5.374-8.35520.785409.862113.05240.389
Other Information:
Effect Of Forex Changes On Cash 0.3620.189-1.123-0.323.169-0.372
Net Change In Cash -17.529-145.579-171.653265.0267.18423.14
Cash At End Of Period 27.50545.034190.613362.26697.24630.062